SNYR Synergy CHC Corp.

BEARISH Impact: 7/10 8-K
Horizon weeks Filed May 14, 2026 Processed 9d 14h ago SEC 0001213900-26-056244
8-K Item 2.02: Earnings release

Price Chart

Loading chart...

Executive Summary

Synergy CHC Corp. reported Q1 2026 revenue of $5.49M, down 32.8% YoY from $8.17M, driven by a non-repeating $1.5M license revenue and online sales disruptions at Flat Tummy. Net loss was ($2.57M) vs. net income of $0.88M a year ago, with EPS of ($0.23) vs. $0.10. Cash burned through operations was $2.0M, and cash dropped to $0.30M from $2.6M at year-end, though $2.7M was raised post-quarter via ATM. The beverage division showed early traction ($650K revenue, $4M annualized run-rate), but the core business is deteriorating sharply.

Key Financial Metrics

Gross Margin
72.3%

Actionable Insight

The core supplement business is contracting sharply while the beverage pivot is still tiny ($650K vs $5.5M total). With only $0.30M cash and a working capital deficit, the $2.7M ATM raise is critical for survival. Watch for further dilution and whether beverage growth can offset core declines before cash runs out.

Key Facts

  • Q1 2026 revenue $5.49M vs $8.17M YoY (-32.8%)
  • Net loss ($2.57M) vs net income $0.88M YoY
  • EPS ($0.23) vs $0.10 YoY
  • Operating loss ($0.57M) vs operating income $1.95M YoY
  • Cash burn from operations $2.0M vs $0.82M YoY
  • Cash dropped to $0.30M from $2.6M at Dec 2025
  • Working capital deficit of $0.50M vs surplus of $1.78M at Dec 2025
  • Beverage revenue $650K (annualized run-rate >$4M) but total revenue still declining
  • $2.7M raised post-quarter via ATM equity offering
  • Stockholders' deficit widened to ($25.4M) from ($23.1M) at Dec 2025

Financial Impact

Revenue decline of $2.68M YoY; net income swing of ($3.45M) YoY; cash burn accelerating to $2.0M/quarter

revenueepsoperating incomecash flowworking capital

Risk Factors

  • Cash runway less than one quarter without additional financing
  • Core Flat Tummy brand experiencing persistent online sales disruption
  • Stockholders' deficit deepening, potential going concern risk
  • Dilution from ATM program and potential future equity raises

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
88% bullish (8 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-056244
Document: ea0290765-8k_synergy.htm0001213900-26-056244
Document: 0001213900-26-056244-index-headers.html0001213900-26-056244
Document: 0001213900-26-056244-index.html0001213900-26-056244
Document: 0001213900-26-056244.txt0001213900-26-056244
8-K Data (Synthetic)0001213900-26-056244
7 reports for SNYR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SNYR — sortable, filterable
Type Now
May 18, 2026
5d ago
8-K
BEARISH ★ 7/10
$0.2868 awaiting T+20awaiting T+20$0.2550 (+11.09%)
May 15, 2026
8d ago
S-1
BEARISH ★ 7/10
$0.2868 awaiting T+20awaiting T+20$0.2550 (+11.09%)
May 14, 2026
9d ago
8-K
BEARISH ★ 7/10
$0.3056 awaiting T+20awaiting T+20$0.2550 (+16.56%)
May 14, 2026
9d ago
Press Release
BEARISH ★ 8/10
$0.3056 awaiting T+20awaiting T+20$0.2550 (+16.56%)
Apr 1, 2026
7w ago
Press Release
BEARISH ★ 7/10
$1.02 $0.3270▲ +67.94%▲ +77.66%$0.2550 (+75.00%)
Mar 30, 2026
7w ago
Press Release
NEUTRAL ★ 2/10
$1.29 $0.3504▼ −72.84%▼ −82.26%$0.2550 (−80.23%)
Mar 17, 2026
9w ago
Press Release
NEUTRAL ★ 3/10
$1.33 $0.5070▼ −61.88%▼ −67.93%$0.2550 (−80.83%)
Showing 7 of 7

US Market Status

Market Closed — Opens Tue (34h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access